| 10435155 |
1999 |
CYP1A1 m2/m2 |
NA |
CYP1A1 |
Details |
| 10793329 |
2000 |
CYP1A1 polymorphism |
NA |
CYP1A1 |
Details |
| 10793329 |
2000 |
GSTM1 polymorphism |
NA |
GSTM1 |
Details |
| 11807792 |
2002 |
TP53 codon 72 polymorphism |
NA |
TP53 |
Details |
| 12543777 |
2003 |
IGF2R polymorphisms |
NA |
IGF2R |
Details |
| 15365571 |
2004 |
(GT)n repeat allele in HO-1 promoter |
NA |
HMOX1 |
Details |
| 15878757 |
2005 |
GSTT1 polymorphism |
NA |
GSTT1 |
Details |
| 16202081 |
2005 |
TNF-a polymorphism |
NA |
TNF |
Details |
| 21432116 |
2005 |
GSTA1 polymorphism |
NA |
GSTA1 |
Details |
| 16256416 |
2006 |
MMP-1 1G/2G polymorphism |
NA |
MMP1 |
Details |
| 17342343 |
2007 |
TIMP-2 -418 G/C polymorphism |
NA |
TIMP1 |
Details |
| 17418617 |
2008 |
ECRG2 STR TCA3/TCA3 |
NA |
SPINK7 |
Details |
| 18251939 |
2008 |
CCND1 A870G mutation |
NA |
CCND1 |
Details |
| 18251939 |
2008 |
P21/WAF1 C98A mutation |
NA |
CDKN1A |
Details |
| 18312299 |
2008 |
HMOX-1 promoter polymorphism |
NA |
HMOX1 |
Details |
| 19596922 |
2009 |
L-MYC polymorphism |
Recurrence |
MYCL |
Details |
| 20952745 |
2010 |
VDR Taq I polymorphism |
NA |
VDR |
Details |
| 21530363 |
2011 |
EGFR CA SSR1 |
NA |
EGFR |
Details |
| 21705789 |
2011 |
ADH1C HaeIII polymorphisms |
NA |
ADH1C |
Details |
| 21705789 |
2011 |
ADH1C SspI*2/*2 polymorphisms |
NA |
ADH1C |
Details |
| 21705789 |
2011 |
CYP2E1 Ins polymorphisms |
NA |
CYP2E1 |
Details |
| 21705789 |
2011 |
CYP2E1 RsaI polymorphisms |
NA |
CYP2E1 |
Details |
| 21875259 |
2011 |
GSTP1 polymorphism |
NA |
GSTP1 |
Details |
| 23227881 |
2013 |
VEGF+405 G/C |
Survival |
VEGFA |
Details |
| 23227881 |
2013 |
VEGF+936 C/T |
NA |
VEGFA |
Details |
| 23227881 |
2013 |
VEGF-1154 G/A |
NA |
VEGFA |
Details |
| 23227881 |
2013 |
VEGF-2578 C/A |
NA |
VEGFA |
Details |
| 23227881 |
2013 |
VEGF-460 C/T |
NA |
VEGFA |
Details |
| 23683469 |
2013 |
TP53 (Pro72Arg) polymorphism |
NA |
TP53 |
Details |
| 24277457 |
2014 |
NOTCH1 mutation |
Metastasis, Recurrence, and Survival |
NOTCH1 |
Details |
| 24277457 |
2014 |
TP53 mutation |
NA |
TP53 |
Details |
| 25341694 |
2014 |
MTHFR C677T polymorphisms |
NA |
MTHFR |
Details |
| 25341694 |
2014 |
TYMS 2R3R genotype |
NA |
TYMS |
Details |
| 25341694 |
2014 |
TYMS 3R3R genotype |
NA |
TYMS |
Details |
| 25821378 |
2015 |
GSTM1 null |
NA |
GSTM1 |
Details |
| 26005639 |
2015 |
IL-6 (- 174) G/C gene polymorphism |
Staging |
IL6 |
Details |
| 26005639 |
2015 |
IL-6 (- 572) G/C gene polymorphism |
NA |
IL6 |
Details |
| 26544895 |
2016 |
GDF15 mutation |
NA |
GDF15 |
Details |
| 26565993 |
2016 |
ALDOC Arg42 mutation |
NA |
ALDOC |
Details |
| 26565993 |
2016 |
ALDOC Lys147 mutation |
NA |
ALDOC |
Details |
| 27350666 |
2016 |
IL10 A1082G polymorphism |
NA |
IL10 |
Details |
| 27774577 |
2017 |
MTHFR C677 polymorphism |
NA |
MTHFR |
Details |
| 28448977 |
2017 |
APE-Asp149Glu polymorphism |
NA |
APEX1 |
Details |
| 28448977 |
2017 |
HOGG1-Ser326Cys polymorphism |
NA |
OGG1 |
Details |
| 28639054 |
2017 |
XRCC1 Arg399Gln polymorphism |
NA |
XRCC1 |
Details |
| 28639054 |
2017 |
XRCC3 Thr241Met polymorphism |
NA |
XRCC3 |
Details |
| 28694429 |
2017 |
EGFR CA repeats polymorphism |
Tumorigenesis |
EGFR |
Details |
| 28904918 |
2017 |
GSTM1 null |
NA |
GSTM1 |
Details |
| 28904918 |
2017 |
GSTM3 AB + BB |
NA |
GSTM3 |
Details |
| 28904918 |
2017 |
GSTT1 null |
NA |
GSTT1 |
Details |
| 28938622 |
2017 |
NOTCH1 mutation |
NA |
NOTCH1 |
Details |
| 28938622 |
2017 |
TP53 mutation |
NA |
TP53 |
Details |
| 29321718 |
2018 |
NOTCH1 C1133Y mutation |
Invasion and Proliferation |
NOTCH1 |
Details |
| 29675970 |
2018 |
HIF-1alpha C1772T polymorphism |
NA |
HIF1A |
Details |
| 30030939 |
2018 |
HLA-G 14-bp InDel polymorphism |
NA |
HLA-G |
Details |
| 30041611 |
2018 |
CASP8 mutation |
NA |
CASP8 |
Details |
| 30041611 |
2018 |
CDKN2A mutation |
NA |
CDKN2A |
Details |
| 30041611 |
2018 |
NOTCH1 mutation |
NA |
NOTCH1 |
Details |
| 30041611 |
2018 |
TP53 mutation |
NA |
TP53 |
Details |
| 30511628 |
2018 |
COX2 -1195 polymorphisms |
NA |
MT-CO2 |
Details |
| 30511628 |
2018 |
COX2 -765 polymorphisms |
NA |
MT-CO2 |
Details |
| 32792479 |
2020 |
NOTCH1 C1133Y mutation |
NA |
NOTCH1 |
Details |
| 33309268 |
2021 |
NFK-519 polymorphisms |
NA |
NFKB1 |
Details |
| 33309268 |
2021 |
Pro72 variant of TP53 |
NA |
TP53 |
Details |
| 33309268 |
2021 |
XRCC3 T241 M polymorphisms |
NA |
XRCC3 |
Details |
| 33993060 |
2021 |
NOTCH1 c.1649 mutation |
Staging |
NOTCH1 |
Details |
| 33993060 |
2021 |
NOTCH1 c.3614 mutation |
Staging |
NOTCH1 |
Details |
| 33993060 |
2021 |
NOTCH1 c.1903+23_1903+33del mutation |
Staging |
NOTCH1 |
Details |
| 33993060 |
2021 |
NOTCH1 c.1978_1985dup mutation |
Staging |
NOTCH1 |
Details |
| 36586077 |
2022 |
MAP2K5 mutation |
Staging and Tumorigenesis |
MAP2K5 |
Details |
| 36586077 |
2022 |
OTX2 mutation |
Staging and Tumorigenesis |
OTX2 |
Details |
| 36586077 |
2022 |
ZFAND5 mutation |
Staging and Tumorigenesis |
ZFAND5 |
Details |
| 36586077 |
2022 |
ADGRG1 mutation |
Staging and Tumorigenesis |
ADGRG1 |
Details |
| 36586077 |
2022 |
SLC35G5 mutation |
Staging and Tumorigenesis |
SLC35G5 |
Details |
| 36586077 |
2022 |
CPNE1 mutation |
Staging and Tumorigenesis |
CPNE1 |
Details |
| 36586077 |
2022 |
IVL mutation |
Staging and Tumorigenesis |
IVL |
Details |
| 36586077 |
2022 |
SLC5A12 mutation |
Staging and Tumorigenesis |
SLC5A12 |
Details |
| 36586077 |
2022 |
VRTN mutation |
Staging and Tumorigenesis |
VRTN |
Details |
| 36586077 |
2022 |
CDC27 mutation |
Staging and Tumorigenesis |
CDC27 |
Details |
| 36586077 |
2022 |
ZNF266 mutation |
Staging and Tumorigenesis |
ZNF266 |
Details |
| 36586077 |
2022 |
FOXC1 mutation |
Staging and Tumorigenesis |
FOXC1 |
Details |
| 36586077 |
2022 |
DPH1 mutation |
Staging and Tumorigenesis |
DPH1 |
Details |
| 36586077 |
2022 |
INTS9 mutation |
Staging and Tumorigenesis |
INTS9 |
Details |
| 36586077 |
2022 |
ANAPC2 mutation |
Staging and Tumorigenesis |
ANAPC2 |
Details |
| 36586077 |
2022 |
FOXK1 mutation |
Staging and Tumorigenesis |
FOXK1 |
Details |
| 36586077 |
2022 |
ZNF333 mutation |
Staging and Tumorigenesis |
ZNF333 |
Details |
| 36586077 |
2022 |
HOXD3 mutation |
Staging and Tumorigenesis |
HOXD3 |
Details |
| 36586077 |
2022 |
SIAH2 mutation |
Staging and Tumorigenesis |
SIAH2 |
Details |
| 36586077 |
2022 |
DDOST mutation |
Staging and Tumorigenesis |
DDOST |
Details |
| 36586077 |
2022 |
WIZ mutation |
Staging and Tumorigenesis |
WIZ |
Details |
| 36586077 |
2022 |
LRRC74A mutation |
Staging and Tumorigenesis |
LRRC74A |
Details |
| 36586077 |
2022 |
MTPAP mutation |
Staging and Tumorigenesis |
MTPAP |
Details |
| 36586077 |
2022 |
AP5M1 mutation |
Staging and Tumorigenesis |
AP5M1 |
Details |
| 36586077 |
2022 |
RAD17 mutation |
Staging and Tumorigenesis |
RAD17 |
Details |
| 36586077 |
2022 |
KCNG4 mutation |
Staging and Tumorigenesis |
KCNG4 |
Details |
| 36586077 |
2022 |
LRRFIP1 mutation |
Staging and Tumorigenesis |
LRRFIP1 |
Details |
| 36586077 |
2022 |
ARHGEF39 mutation |
Staging and Tumorigenesis |
ARHGEF39 |
Details |
| 36586077 |
2022 |
GRXCR1 mutation |
Staging and Tumorigenesis |
GRXCR1 |
Details |
| 36586077 |
2022 |
ADAM32 mutation |
Staging and Tumorigenesis |
ADAM32 |
Details |
| 36586077 |
2022 |
AKR7L mutation |
Tumorigenesis |
AKR7L |
Details |
| 37828627 |
2023 |
ATP7A mutation |
NA |
ATP7A |
Details |
| 37828627 |
2023 |
ATP7B mutation |
NA |
ATP7B |
Details |
| 37828627 |
2023 |
DLST mutation |
NA |
DLST |
Details |
| 37828627 |
2023 |
FDX1 mutation |
NA |
FDX1 |
Details |
| 37828627 |
2023 |
DLAT mutation |
NA |
DLAT |
Details |
| 37828627 |
2023 |
PDHA1 mutation |
NA |
PDHA1 |
Details |
| 37828627 |
2023 |
DBT mutation |
NA |
DBT |
Details |
| 37828627 |
2023 |
PDHB mutation |
NA |
PDHB |
Details |